Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
09/03/20245:15PMBusiness WireNews Corp's Move, Inc. to Participate in Goldman Sachs Communacopia + Technology ConferenceNASDAQ:NWSANews Corporation
09/03/20245:15PMBusiness WireNews Corp's Move, Inc. to Participate in Goldman Sachs Communacopia + Technology ConferenceNASDAQ:NWSNews Corporation
09/03/20245:15PMBusiness WireNews Corp's Move, Inc. to Participate in Goldman Sachs Communacopia + Technology ConferenceASX:NWSLVNews Corporation
09/03/20245:14PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:ARDCAres Dynamic Credit Allocation Fund Inc
09/03/20245:14PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASNDAscendis Pharma AS
09/03/20245:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CWTCalifornia Water Service Group
09/03/20245:14PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:VATEINNOVATE Corp
09/03/20245:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCABBioAtla Inc
09/03/20245:14PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KOPNKopin Corporation
09/03/20245:14PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NVDANVIDIA Corporation
09/03/20245:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CYTKCytokinetics Inc
09/03/20245:14PMGlobeNewswire Inc.Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding AgreementNASDAQ:RPRXRoyalty Pharma PLC
09/03/20245:14PMGlobeNewswire Inc.Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding AgreementNASDAQ:ASNDAscendis Pharma AS
09/03/20245:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LEN.BLennar Corp
09/03/20245:14PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:MS-PMorgan Stanley
09/03/20245:13PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
09/03/20245:13PMEdgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNYSE:CBZCBIZ Inc
09/03/20245:13PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:JELDJELD WEN Holding Inc
09/03/20245:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
09/03/20245:12PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRMDTORM PLC
09/03/20245:12PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:BNSBank Nova Scotia Halifax
09/03/20245:12PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NTRBNutriband Inc
09/03/20245:12PMPR Newswire (US)Kensington Asset Management Aims to Enhance the Derivative Income Space with Launch of First ETF: Kensington Hedged Premium Income (KHPI)
09/03/20245:11PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASNDAscendis Pharma AS
09/03/20245:11PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:BNSBank Nova Scotia Halifax
09/03/20245:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LZBLa Z Boy Inc
09/03/20245:10PMEdgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:RYRoyal Bank of Canada
09/03/20245:10PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ASNDAscendis Pharma AS
09/03/20245:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CMAXCareMax Inc
09/03/20245:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KINSKingstone Companies Inc